Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy by Nisha Holay, Nisha Holay, Alexander Somma, Mark Duchow, Milad Soleimani, Milad Soleimani, Anna Capasso, Srividya Kottapalli, Joshua Rios, Uma Giri, Jennifer Diamond, Jennifer Diamond, Anna Schreiber, Anthony D. Piscopio, Carla Van Den Berg, Carla Van Den Berg, Carla Van Den Berg, S. Gail Eckhardt, S. Gail Eckhardt, Todd A. Triplett, Todd A. Triplett

Get full text